Report: FDA approved the most drugs in 4 years in 2009

01/5/2010 | Wall Street Journal, The

The FDA approved 26 new treatments in 2009, the most in four years but only one more than in 2008, according to a Washington Analysis report. Blood thinner Effient, by Eli Lilly and Co. and Daiichi Sankyo, and Sanofi-Aventis' heart drug Multaq were among the approvals, while Novo Nordisk's liraglutide for diabetes and Amgen's osteoporosis drug denosumab failed to secure approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA